Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathy.

E M Kohner, N W Oakley

    Metabolism: Clinical and Experimental
    |September 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Diabetic retinopathy affects many long-term diabetics, potentially causing blindness. Understanding its progression and exploring treatments like photocoagulation are key to managing this complication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arterial Fluorescein Studies in Diabetic Retinopathy.

    Proceedings of the Royal Society of Medicine·2009
    Same author

    Microvascular disease: what does the UKPDS tell us about diabetic retinopathy?

    Diabetic medicine : a journal of the British Diabetic Association·2008
    Same author

    Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy.

    Diabetologia·2006
    Same author

    Quality assurance for diabetic retinopathy telescreening.

    Diabetic medicine : a journal of the British Diabetic Association·2005
    Same author

    The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency.

    Clinical endocrinology·2003
    Same author

    Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).

    Diabetic medicine : a journal of the British Diabetic Association·2001
    Same journal

    Ablation of microglial estrogen receptor alpha predisposes male mice to diet-induced obesity.

    Metabolism: clinical and experimental·2026
    Same journal

    Pathophysiology-based subtypes of individuals at high-risk of type 2 diabetes: multi-omics profiles and lifestyle differences across subtypes.

    Metabolism: clinical and experimental·2026
    Same journal

    A thermosensitive TET-Parkin epigenetic axis couples mitochondrial quality control to adaptive thermogenesis in adipose tissue.

    Metabolism: clinical and experimental·2026
    Same journal

    Raffinose targets the NQO1/NF-κB axis to attenuate DON-driven microglial activation and neuroinflammation via metabolic reprogramming.

    Metabolism: clinical and experimental·2026
    Same journal

    Endothelial NPR-C promotes insulin resistance via Caveolin-1-mediated insulin transcytosis.

    Metabolism: clinical and experimental·2026
    Same journal

    Macrophage-enriched GPR91 aggravates acute liver injury by inhibiting efferocytosis via the AC/cAMP/PPARγ pathway.

    Metabolism: clinical and experimental·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Endocrinology
    • Diabetology

    Background:

    • Diabetic retinopathy is a major cause of blindness in adults aged 30-65.
    • It affects 60%-80% of long-term diabetics, with a poor prognosis after diagnosis.
    • Understanding the natural history and risk factors is crucial for effective management.

    Purpose of the Study:

    • To review the natural history and current understanding of diabetic retinopathy.
    • To discuss potential causes and contributing factors.
    • To evaluate current and emerging treatment modalities.

    Main Methods:

    • Review of existing literature on diabetic retinopathy.
    • Documentation of changes using retinal photography and grading systems.
    • Analysis of evidence for genetic factors, hormonal influences, and metabolic changes.

    Related Experiment Videos

    Main Results:

    • Diabetic retinopathy progresses from background to maculopathy or proliferative stages.
    • Causes remain unclear, but genetic, hormonal, and metabolic factors are implicated.
    • Good diabetic control and photocoagulation show promise in management.

    Conclusions:

    • Diabetic retinopathy is a serious complication with significant visual impairment risk.
    • Further research into causes and refined treatment strategies, including photocoagulation and vitreous surgery, is warranted.
    • Patient education and adherence to diabetic control are paramount.